Rifaximin | Interleukin Related interleukin-related.com

Product Name :
Rifaximin

Search keywords :
RNA Polymerase beta

drugId :
null

Target Vo:
DNA-directed RNA polymerase beta chain

Target Vo Short Name :
rpoB

Moa_Name:
DNA-directed RNA polymerase beta chain inhibitors

First Approval Country :

First Approval Date Filter:
1985

Origin Company_Name :

Active Company_Name :
Alfasigma Spa

Active Indication_Name:
Hyperammonemia

In Active Indication_Name:
HIV Infections

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FGFR2/CD332 Antibody
Flotillin 1 Antibody (YA760)
Phospho-p95/NBS1 (Ser343) Antibody: Phospho-p95/NBS1 (Ser343) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Phospho-p95/NBS1 (S343). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts